ARCHIVES

Lasagna Committee Report Advocates Faster Drug approval, Insurance Coverage For Investigational Drugs, Ancillary Costs

This article is from The Cancer Letter archive.

Vol. 16 No. 34 | September 7, 1990

Download PDF Visit The Full Archive

Related Articles

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Business & Regulatory Report March edition (8 pages) included.

March 19, 2004

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

NCI Programs: Advisors Approve Recompetition of Phase II Contracts

July 9, 1999

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

House Bill, Report Do Not Include Any Earmarks Or Directives To Aid CCOP, Centers, Cancer Control

August 7, 1987